Available Trial Results Summaries AFFINITY - NCT03222973 Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
View Trial Results summary - Czech (Czech Republic)
View Trial Results summary - Dutch (Belgium)
View Trial Results summary - Dutch (Netherlands)
View Trial Results summary - English (Master)
View Trial Results summary - French (Belgium)
View Trial Results summary - French (Canada)
View Trial Results summary - French (France)
View Trial Results summary - German (Germany)
View Trial Results summary - German (Switzerland)
View Trial Results summary - Hebrew (Israel)
View Trial Results summary - Hungarian (Hungary)
View Trial Results summary - Italian (Italy)
View Trial Results summary - Italian (Switzerland)
View Trial Results summary - Polish (Poland)
View Trial Results summary - Spanish (Spain)